Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Trajan Group.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health: Invex gets ready for Phase 3, Medlab gets US patent. Both jump 13pc this morning
News
IPO Watch: With a 950pc gain in 3 weeks, Kuniko is easily 2021’s top ASX listing
Health & Biotech
ASX Health Stocks: Dimerix commences Phase 3 trial, while IDT scoots 10pc after restoring profit
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
IPO Watch
IPO Watch: Which sector has provided the best performing IPOs in 2021?
IPO Watch
IPO Watch: Metals and rare earth explorers light up the ASX IPO scene
Health & Biotech
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed
IPO Watch
IPO Watch: Trajan founder and CEO on bootstrapping his company all the way to the ASX
News
Rise and Shine: What you need to know before the ASX opens
News
Last Orders: ASX finishes the day down, tech rockets 2.81 per cent
News
